About Us
Advancing molecular farming and plant biotechnology through European scientific collaboration, innovative recombinant protein production, and the development of safe, scalable plant-based pharmaceutical manufacturing platforms.
A European Leader in Molecular Farming
The Pharma-Planta Consortium was one of Europe's largest collaborative research initiatives dedicated to advancing molecular farming, plant-made pharmaceutical proteins, and plant biotechnology. Supported by the European Union Sixth Framework Programme (FP6), the consortium united internationally recognized universities, biotechnology institutes, research organizations, industrial partners, and regulatory experts with one common objective: demonstrating that plants could become reliable manufacturing platforms for high-value recombinant pharmaceutical proteins.
By integrating expertise from molecular biology, recombinant protein expression, plant genetics, biotechnology, biosafety, immunology, quality assurance, manufacturing, and regulatory science, Pharma-Planta established an interdisciplinary research environment capable of transforming innovative laboratory discoveries into practical production technologies suitable for future pharmaceutical manufacturing.
The consortium successfully demonstrated that genetically engineered plants can serve as efficient biological factories capable of producing complex recombinant proteins while supporting scalable manufacturing, high product quality, and rigorous regulatory compliance. This work positioned Europe among the pioneers of modern plant molecular farming technologies.
33+
Academic & Industrial Partners
FP6
EU Framework Programme
2011
Phase I Clinical Milestone
Our Mission
Our mission was to establish a scientifically validated and regulatory-compliant production platform for recombinant pharmaceutical proteins produced in plants. Beyond developing innovative plant expression technologies, Pharma-Planta aimed to create manufacturing standards, biosafety procedures, environmental risk assessment strategies, and quality systems capable of supporting future clinical development and commercial production.
The project emphasized responsible innovation by combining biotechnology research with regulatory engagement, ensuring that every stage of development—from genetic engineering and protein expression to greenhouse cultivation and manufacturing—met the highest European scientific and safety standards.
🌱 Scientific Innovation
Developing next-generation molecular farming technologies capable of producing complex recombinant proteins using advanced plant biotechnology.
🧬 Biotechnology Excellence
Combining expertise in molecular biology, recombinant DNA technology, plant genetics, protein engineering, and expression systems.
🛡 Biosafety
Establishing comprehensive environmental risk assessment and biosafety practices supporting responsible plant-based pharmaceutical production.
⚙ GMP Manufacturing
Creating production workflows compatible with Good Manufacturing Practice (GMP) principles for future pharmaceutical manufacturing.
🤝 European Collaboration
Bringing together multidisciplinary expertise from leading universities, biotechnology companies, regulatory specialists, and research institutions.
🚀 Future Technologies
Supporting continuous innovation in recombinant protein production, plant expression systems, molecular farming, and plant-derived biologics.
Our Scientific Journey
Building the Consortium
Establishing one of Europe's largest multidisciplinary collaborations focused on molecular farming and plant biotechnology research.
Technology Development
Developing innovative recombinant protein expression technologies, transgenic plant platforms, manufacturing strategies, and quality systems.
Regulatory Integration
Working closely with European regulatory authorities to establish biosafety, environmental risk assessment, and GMP-compatible production processes.
Clinical Achievement
Successfully advancing a plant-derived pharmaceutical candidate into a Phase I clinical trial, representing an important milestone in molecular farming.
Driving the Future of Plant-Based Biomanufacturing
Today, the scientific achievements of Pharma-Planta continue to influence research in molecular farming, plant-made pharmaceuticals, recombinant protein expression, plant biotechnology, synthetic biology, biopharmaceutical manufacturing, and advanced plant expression systems. The consortium demonstrated that plants can become sophisticated production platforms capable of supporting innovative biotechnology applications while maintaining rigorous standards for quality, biosafety, scalability, and scientific excellence.